Philip Morris Canada WHO World Health Organization Philip Morris Canada

WHO rejects Medicago’s COVID-19 vaccine due to ties to tobacco giant

Reading now: 643
globalnews.ca

The first Canadian-made COVID-19 vaccine by Medicago has been rejected by the World Health Organization (WHO) due to its ties to tobacco giant Philip Morris “We are aware that the WHO updated Medicago’s vaccine status to ‘not accepted.’ We have received an email which indicated the WHO’s preliminary decision and informed us that official communication outlining the details and rationale would follow,” wrote Medicago President and CEO Takashi Nagao in a statement to Global News on Friday. “Once we receive this, we will review the rationale and continue to discuss next steps with our partners and shareholders.” “It is our understanding that this decision is linked to Medicago’s minority shareholder and not the demonstrated safety and efficacy profile of our COVID-19 vaccine.

Covifenz was approved by Health Canada on February 24, 2022.” Philip Morris, the biggest tobacco company in the world, owns one-third of Quebec-based Medicago.

The government of Canada invested $173-million in Medicago and its efforts to create a viable COVID-19 vaccine. Medicago’s COVID-19 vaccine, Covifenz, received approval from Health Canada on Feb.

24. The home-grown vaccine is the world’s first-ever plant-based jab authorized for human use and is also the first Canadian shot to be approved in over 20 years.

Read more on globalnews.ca
The website covid-19.rehab is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.

Related News

DMCA